Venture Capital
In 20+ years in Silicon Valley I have both seen, advised and sometimes dissuaded foreign entrepreneurs about coming to the US....
In a recent conversation with a young woman founder, I was asked whether founders should raise their first institutional round from...
Startups get interest from strategic investors all the time. We expect that interest to become more pronounced given the current market...
Almost every day I get asked about how investing in a VC fund is different from a startup. So this is...
For startups, especially at the early stages, finding and hiring technical talent is the single biggest bottleneck. This is a post...
The pandemic has catalyzed technology adoption within healthcare, and thus indirectly, has accelerated the evolution of physicians’ role within medicine and...
Excited to announce our investment alongside Bonfire Ventures, Insight Partners and the Allen Institute for AI in the $4M seed for...
This is a continuation of the article: Medicare / Medicaid / Advantage — Where Are The Opportunities For Startups? — Part...
AmplifyMD is a platform for all specialty needs: it connects. Excited to be investors alongside F Prime (Fidelity), Greylock and Forerunner...
Excited to announce our investment in Arpeggio Bio, which engineers drugs to change the transcriptome, with the goal of making safer...
Medicare, Medicaid, Medicare Advantage. The words often get thrown around and are mixed with generalized association of government social programs for...
“July 21, 2022 at 8:30 AM EDT – Amazon and One Medical Sign an Agreement for Amazon to Acquire One Medical...
The COVID pandemic has catalyzed an unimaginably rapid adoption of virtual care. Virtual disease management service offerings, and the demand for...
A startup worth evaluation reminds me of a coin toss. With no operational value, real income, or сlear-eyed market feedback, tangible...
Direct-to-consumer healthcare. We see it more and more, and it is an increasing trend that’s been written about extensively (see: health-tech...
As the economy takes a downturn in the second quarter of 2022, and gloomy projections of the market have translated into...
You hear these terms all the time. Countless articles (here, here, here) enumerate the various metrics that can quantify the growth...
Excited to announce our investment alongside General Catalyst, Resolute, Canaan and The Fund in the $7M seed of Hank, which helps...
This blog has talked at length in the past about how to raise a round, especially a seed, and building an...
A previous article Secondaries: Founders and Investors defined a secondary as when you sell your existing shares to another investor. Secondaries...
4Ps, PPO, HMO, MCO, ACO, VFVB, CMS, PMPM, PBM – the list of acronyms is long, see Appendix. But cut through...
The earlier a startup is, the more buffered it’s from the ups and downs of public markets. But buffered doesn’t mean...
Excited to announce our investment in Resilient Lifescience, which is taking on the opioid epidemic by developing a wearable system to...
Most startups will face the prospect of a lower valuation than they wanted at some point. Which is why raising too...
Load More Posts
